The Long Noncoding RNA MALAT1/microRNA-598-3p Axis Regulates the Proliferation and Apoptosis of Retinoblastoma Cells Through the PI3K/AKT Pathway
Overview
Molecular Biology
Ophthalmology
Authors
Affiliations
Purpose: This study was designed to dissect the role of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in retinoblastoma (RB) and its underlying mechanism.
Methods: Gain- and loss-of-function experiments were adopted to explore the effects of MALAT1 and microRNA (miR)-598-3p on the biologic behaviors of RB cells. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to assess the expression of MALAT1 and miR-598-3p in Y79 and HXO-RB44 cells. The proliferation of RB cells was determined with the cell counting kit-8 (CCK-8) assay and 5-ethynyl-2'-deoxyuridine (EdU) staining. Flow cytometry was employed for the measurement of the apoptotic rate, western blotting for examination of the expression of apoptosis-related proteins (Bax and Bcl-2) and phosphoinositide 3-kinase/protein kinase-B (PI3K/AKT) pathway-related factors (PI3K, AKT, p-PI3K, and p-AKT), and the luciferase reporter assay for assessment of the interaction between MALAT1 and miR-598-3p.
Results: High expression of MALAT1 and low expression of miR-598-3p were noticed in Y79 and HXO-RB44 cells. MALAT1 upregulation or miR-598-3p downregulation facilitated RB cell proliferation and inhibited cell apoptosis, as evidenced by the increased proliferation rate and Bcl-2 expression, as well as diminished Bax expression and apoptotic rate, in the RB cells after transfection with pcDNA3.1-MALAT1 or miR-598-3p inhibitor. MALAT1 bound to and negatively regulated miR-598-3p. The PI3K/AKT pathway activation occurred with MALAT1 overexpression. MALAT1 promoted RB cell proliferation and repressed cell apoptosis by repressing miR-598-3p to activate the PI3K/AKT pathway.
Conclusions: MALAT1 repressed miR-598-3p to activate the PI3K/AKT pathway, thus facilitating cell proliferation and inhibiting cell apoptosis in RB.
Detection of early relapse in multiple myeloma patients.
Ruzickova T, Vlachova M, Pecinka L, Brychtova M, Vecera M, Radova L Cell Div. 2025; 20(1):4.
PMID: 39881385 PMC: 11776158. DOI: 10.1186/s13008-025-00143-3.
MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A Review.
Dymanowska I, Frankowska K, Krawczyk A, Kociuba J, Gil-Kulik P, Banaszewska B Med Sci Monit. 2024; 30:e946480.
PMID: 39709519 PMC: 11670786. DOI: 10.12659/MSM.946480.
Yang G, Huang Y, Li D, Tang J, Li W, Huang X Int Ophthalmol. 2024; 44(1):363.
PMID: 39227412 DOI: 10.1007/s10792-024-03295-3.
Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases.
Nasrolahi A, Pour F, Salehi A, Kempisty B, Hajizadeh M, Feghhi M J Cell Commun Signal. 2023; 17(4):1203-1217.
PMID: 37870615 PMC: 10713964. DOI: 10.1007/s12079-023-00787-2.
LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.
Mazarei M, Rabori V, Ghasemi N, Salehi M, Rayatpisheh N, Jahangiri N Clin Exp Med. 2023; 23(8):4457-4472.
PMID: 37695391 DOI: 10.1007/s10238-023-01179-x.